Who We Are?
Transforming Smart InventionsInto Smart Investments
Transforming SmartInventions IntoSmart Investments
Every day, thousands of health care professionals treat and care for patients within Clalit Health Services’ huge network. By the bedside, at diagnostic clinics, in ORs and ERs, and community medical centers, they save and improve the quality of life of over 5 million members.
Along the way, they also see and feel the pain, suffering, and discomfort patients often must endure. A desire to help combined with deep knowledge, resourcefulness and creativity sometimes result in discoveries and smart ideas with great commercial potential.
Through its end-to-end technology transfer services, Mor Research Applications helps inventors translate new ideas in the medical devices, pharmaceutical, diagnostics, digital healthcare, and biotech areas into products and solutions that benefit healthcare providers and patients.
At any given time we have over 100 projects at various stages of development, from pre-seed and up to spin-off. We work to maximize the potential of the idea by securing the rights to the intellectual property, bringing on the right partners, and promoting these smart investments. We facilitate cooperation of our physicians with academic institutions or companies that can turn their ideas into products and technologies.
Since its establishment in 1994, Mor Research Applications has been the Technology Transfer Office of Clalit Health Services, Israel's largest HMO. Over three decades of experience ensure that the process of commercialization of these inventions yields gains for their researchers, industry partners, investors, and the public at large.
Mor's role starts from the initial inventor's idea review, patent filing, raising early funding, and continues by taking it to the stage where it is ready to be commercialized.
Mor Research Application serves professionals working at all fourteen hospitals owned by Clalit (Rabin (Beilinson and HaSharon), Meir, Kaplan, Carmel, Soroka, Ha-Emek, Yossef Tal, Schneider, Geha, Beit Rivka, Harztfeld, Beit Levinshtein, Shalvata) Medical Centers, and around 2,000 community clinics across Israel. Mor's team of professionals work together with the various hospitals to promote innovation by the staff and provide the support they need to make it happen.
MOR draws on over two decades of experience to ensure that the process of commercialization of these inventions yields gains for the researchers, industry partners, and the public at large.
The main role of MOR Research Application is to captureinnovation through its invention disclosure process
evaluate whether the invention has market and patent protection value, secure patent protection, secure licensing agreements or establish spin-offs for further development. In addition to the IP department, MOR serves Clalit’s employees through its research fund division, which currently handles over one thousand funds for Clalit doctors and researchers. Mor was founded in 1994 as a subsidiary of The Mor Institute and a holding of Clalit Health Services.
The Team
Our Experienced Leaders
Our Experienced Leaders
Shay Marcus
Chief Executive Officer
Shay has nearly two decades of experience in international business development and entrepreneurship.
Before joining Mor Research Applications in 2022, Shay was Partner at Sheng Enterprises, a leading Israel-China business development consulting and investment banking firm. Shay was also the Chief Business Officer at Yeda, the commercial arm of the Weizmann Institute of Science, where he was responsible for all business development activities.
Prior to that, Shay was VP of Business Development and Marketing of one of Israel’s largest technological Incubators, where he was involved in new investments, as well as supporting startups in business development activities.
Shay holds an M.Sc. in life sciences from the Weizmann Institute of Science.
Lena Shot
Chief Finance Officer
Lena joined Mor Research Application in 2020. She has over 24 years of experience in financial management as an accountant and CPA. Before joining Mor, she served for 14 years as a senior accountant at various hospitals of Clalit Health Services, where she gained vast experience in managing research funds.
Lena holds a B.A. in Business Management from the College of Management in Rishon Lezion, Israel.
Amitai Shapira
General Counsel
Amitai has been the general and legal counsel of Mor since 2022 after a decade of serving in leading law firms in the field of intellectual property (litigation and commercial).
He did his legal internship at the Israeli Money Laundering and Terror Financing Prohibition Authority (IMPA).
Amitai holds a LL.B. from Bar Ilan University and a BA in Philosophy from Tel Aviv University.
Sari Prutchi Sagiv PhD
Tech Transfer Director,Pharma And Diagnostics
Sari has been with Mor Research Applications since 2006, and has extensive experience in taking projects to the start-up stage. She has led the scientific, regulatory, business development and marketing strategies in life science projects from seed and early stage through capital raising and through to forming partnerships with top tier strategic investors.
She manages the clinical development of several of our spinoff companies in the field of cannabinoid research. She also acts as a member of the Board of Directors at Bonfix and other cannabis development companies.
Sari studied Business Administration at Tel Aviv University, and holds an M.Sc. in Human Genetics and a Ph.D. in Cell Biology and Immunology from the same University.
David Bonfil PhD
Intellectual Property Manager
Avital Pritz
Director Tech Transfer,Medical Devices And Digital Health
An experienced executive, Avital has been in the medtech and pharma sectors since 2011.
While working at a consulting firm specialized in doing business in Japan, she assisted numerous Israeli companies, both startups and mature multinational corporations in penetrating the market. Avital also provided scouting services for Japanese multinational companies seeking to identify investment and acquisition opportunities in disruptive technologies.
Prior to that, she worked for Abbott Laboratories and the Gertner Institute in regulatory and clinical positions in which she monitored clinical trials, and also prepared and submitted regulatory documents to the Ministry of Health.
Avital holds a B.Sc in Medical and Life Sciences from Tel Aviv University and an MBA from Tel Aviv Jaffa Academy.
Contact Mor Research
You are welcomed to get in touch with us or leave us your details and we will come back to you as soon as possible.
-
+972-3-9233227
-
mor@mor-research.com
-
+972-3-9233228